377 related articles for article (PubMed ID: 25453780)
1. An accidental poisoning with mitragynine.
Karinen R; Fosen JT; Rogde S; Vindenes V
Forensic Sci Int; 2014 Dec; 245():e29-32. PubMed ID: 25453780
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the rewarding effects of mitragynine and 7-hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats.
Behnood-Rod A; Chellian R; Wilson R; Hiranita T; Sharma A; Leon F; McCurdy CR; McMahon LR; Bruijnzeel AW
Drug Alcohol Depend; 2020 Oct; 215():108235. PubMed ID: 32889450
[TBL] [Abstract][Full Text] [Related]
3. Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.
Lydecker AG; Sharma A; McCurdy CR; Avery BA; Babu KM; Boyer EW
J Med Toxicol; 2016 Dec; 12(4):341-349. PubMed ID: 27752985
[TBL] [Abstract][Full Text] [Related]
4. Mitragynine concentrations in two fatalities.
Domingo O; Roider G; Stöver A; Graw M; Musshoff F; Sachs H; Bicker W
Forensic Sci Int; 2017 Feb; 271():e1-e7. PubMed ID: 28089300
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of in vitro absorption, distribution, metabolism, and excretion (ADME) properties of mitragynine, 7-hydroxymitragynine, and mitraphylline.
Manda VK; Avula B; Ali Z; Khan IA; Walker LA; Khan SI
Planta Med; 2014 May; 80(7):568-76. PubMed ID: 24841968
[TBL] [Abstract][Full Text] [Related]
6. A validated method for the quantification of mitragynine in sixteen commercially available Kratom (Mitragyna speciosa) products.
Fowble KL; Musah RA
Forensic Sci Int; 2019 Jun; 299():195-202. PubMed ID: 31059866
[TBL] [Abstract][Full Text] [Related]
7. Development, validation, and application of an LC-MS/MS method for mitragynine and 7-hydroxymitragynine analysis in hair.
Meier U; Mercer-Chalmers-Bender K; Scheurer E; Dussy F
Drug Test Anal; 2020 Feb; 12(2):280-284. PubMed ID: 31833662
[TBL] [Abstract][Full Text] [Related]
8. Human Mitragynine and 7-Hydroxymitragynine Pharmacokinetics after Single and Multiple Daily Doses of Oral Encapsulated Dried Kratom Leaf Powder.
Huestis MA; Brett MA; Bothmer J; Atallah R
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474495
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants.
Wang M; Carrell EJ; Ali Z; Avula B; Avonto C; Parcher JF; Khan IA
J Sep Sci; 2014 Jun; 37(12):1411-8. PubMed ID: 24659356
[TBL] [Abstract][Full Text] [Related]
10. Fatality of 33-Year-Old Man Involving Kratom Toxicity.
Matson M; Schenk N
J Forensic Sci; 2019 Nov; 64(6):1933-1935. PubMed ID: 31121058
[TBL] [Abstract][Full Text] [Related]
11. The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse.
Kruegel AC; Grundmann O
Neuropharmacology; 2018 May; 134(Pt A):108-120. PubMed ID: 28830758
[TBL] [Abstract][Full Text] [Related]
12. Identification of metabolites and potential biomarkers of kratom in urine.
Basiliere S; Kerrigan S
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():121971. PubMed ID: 32058315
[TBL] [Abstract][Full Text] [Related]
13. Lateral Flow Assessment and Unanticipated Toxicity of Kratom.
Smith LC; Lin L; Hwang CS; Zhou B; Kubitz DM; Wang H; Janda KD
Chem Res Toxicol; 2019 Jan; 32(1):113-121. PubMed ID: 30380840
[TBL] [Abstract][Full Text] [Related]
14. Two Single-Drug Fatal Intoxications by Mitragynine.
Behonick GS; Vu C; Czarnecki L; El-Ters M; Shanks KG
J Anal Toxicol; 2022 May; 46(5):e110-e114. PubMed ID: 35285475
[TBL] [Abstract][Full Text] [Related]
15. A case of fatal overdose involving both hydromorphone and kratom.
Shi T; Shea JL
J Forensic Sci; 2024 Jan; 69(1):355-358. PubMed ID: 37753815
[TBL] [Abstract][Full Text] [Related]
16. Rapid detection by direct analysis in real time-mass spectrometry (DART-MS) of psychoactive plant drugs of abuse: the case of Mitragyna speciosa aka "Kratom".
Lesiak AD; Cody RB; Dane AJ; Musah RA
Forensic Sci Int; 2014 Sep; 242():210-218. PubMed ID: 25086346
[TBL] [Abstract][Full Text] [Related]
17. Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine.
Hemby SE; McIntosh S; Leon F; Cutler SJ; McCurdy CR
Addict Biol; 2019 Sep; 24(5):874-885. PubMed ID: 29949228
[TBL] [Abstract][Full Text] [Related]
18. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats.
Kamble SH; Obeng S; León F; Restrepo LF; King TI; Berthold EC; Kanumuri SRR; Gamez-Jimenez LR; Pallares VLC; Patel A; Ho NP; Hampson A; McCurdy CR; McMahon LR; Wilkerson JL; Sharma A; Hiranita T
J Pharmacol Exp Ther; 2023 Jun; 385(3):180-192. PubMed ID: 37019472
[TBL] [Abstract][Full Text] [Related]
20. A drug fatality involving Kratom.
Neerman MF; Frost RE; Deking J
J Forensic Sci; 2013 Jan; 58 Suppl 1():S278-9. PubMed ID: 23082895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
